Showing results (321-330 of 482) with videos related to
Sort By:
Pageof 49
Bioconjugate Chemistry|July 4, 2017
Synthesis and Evaluation of Dimeric Derivatives of Diacylglycerol-Lactones as Protein Kinase C LigandsNami Ohashi, Ryosuke Kobayashi, Wataru Nomura, et al.Immunogenetics|September 2, 2000
An automated prediction of MHC class I-binding peptides based on positional scanning with peptide librariesK Udaka, K H Wiesmüller, S Kienle, et al.Head & Face Medicine|September 26, 2007
A pigmented calcifying cystic odontogenic tumor associated with compound odontoma: a case report and review of literaturePhuu P Han, Hitoshi Nagatsuka, Chong H Siar, et al.Bioorganic & Medicinal Chemistry|April 18, 2012
Evaluation of a synthetic C34 trimer of HIV-1 gp41 as AIDS vaccinesChie Hashimoto, Wataru Nomura, Aki Ohya, et al.Biochimica Et Biophysica Acta|May 13, 1993
A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonanceH Tamamura, M Kuroda, M Masuda, et al.Environmental Toxicology and Chemistry|September 16, 2021
Occurrence of Pharmaceutically Active Compounds and Potential Ecological Risks in Wastewater from Hospitals and Receiving Waters in Sri LankaPrasun Goswami, Keerthi S Guruge, Rumi Tanoue, et al.ACS Omega|September 22, 2025
SARS-CoV‑2 Main Protease Inhibitors Containing 5‑Substituted Benzothiazole-2-carbonyl Moieties at the P1' Site and Their DerivativesKohei Tsuji, Takuya Kobayakawa, Nobuyo Higashi-Kuwata, et al.European Journal of Medicinal Chemistry|May 24, 2023
Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activityTakahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2002
Synthesis and evaluation of pseudopeptide analogues of a specific CXCR4 inhibitor, T140: the insertion of an (E)-alkene dipeptide isostere into the betaII'-turn moietyHirokazu Tamamura, Kenichi Hiramatsu, Kazuhide Miyamoto, et al.Cancer Investigation|June 3, 2009
Loss of heterozygosity at the 9p21-24 region and identification of BRM as a candidate tumor suppressor gene in head and neck squamous cell carcinomaEsra Gunduz, Mehmet Gunduz, Mahmoud Al Sheik Ali, et al.Pageof 49